{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:08:16Z","timestamp":1794258496325,"version":"4.9.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000046","name":"National Research Council Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128182","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:19:46Z","timestamp":1767806386000},"page":"128182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Heterologous vs. homologous vaccine regimens: Sulfated lactosyl archaeol (SLA) archaeosome-adjuvanted SARS-CoV-2 spike protein boost following an mRNA\/LNP prime induces robust and balanced immune responses"],"prefix":"10.1016","volume":"74","author":[{"given":"Tyler M.","family":"Renner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Agbayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiva","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Deschatelets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Dudani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha D.","family":"Hemraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Koukiekolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Stuible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Durocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McCluskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Akache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2025.128182_bb0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1147","key":"10.1016\/j.vaccine.2025.128182_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/postgradmedj-2020-139070","article-title":"COVID-19: a comparison to the 1918 influenza and how we can defeat it","volume":"97","author":"Liang","year":"2021","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0015","first-page":"1","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"24","key":"10.1016\/j.vaccine.2025.128182_bb0020","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2189885","article-title":"The Matrix-M\u2122 adjuvant: A critical component of vaccines for the 21st century","volume":"19","author":"Stertman","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/IAI.68.1.54-63.2000","article-title":"Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum","volume":"68","author":"Krishnan","year":"2000","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0035","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2395081","article-title":"Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant","volume":"20","author":"Akache","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128182_bb0040","first-page":"179","article-title":"Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines","author":"Akache","year":"2022","journal-title":"Vaccine Des"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128182_bb0045","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1021\/acs.jmedchem.2c00072","article-title":"Effect of chiral purity on Adjuvanticity of Archaeol-based glycolipids","volume":"65","author":"R\u00e9gnier","year":"2022","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128182_bb0050","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1080\/21645515.2017.1316912","article-title":"Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity","volume":"13","author":"McCluskie","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128182_bb0055","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/21645515.2020.1788300","article-title":"Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations","volume":"16","author":"Agbayani G, Jia ,Yimei, Akache ,Bassel, Chandan, Vandana, Iqbal, Umar, Stark, Felicity C","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128182_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208067","article-title":"Sulfated archaeol glycolipids: comparison with other immunological adjuvants in mice","volume":"13","author":"Akache","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.128182_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01363-7","article-title":"Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant","volume":"11","author":"Akache","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128182_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1182556","article-title":"Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 omicron variant of concern","volume":"14","author":"Renner","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.128182_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41541-022-00540-7","article-title":"Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern","volume":"7","author":"Akache","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44298-024-00067-9","article-title":"Reduced cross-protective potential of omicron compared to ancestral SARS-CoV-2 spike vaccines against potentially zoonotic coronaviruses","volume":"2","author":"Renner","year":"2024","journal-title":"Npj Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128182_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350620","article-title":"Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters","volume":"54","author":"Agbayani","year":"2024","journal-title":"Eur J Immunol"},{"issue":"10324","key":"10.1016\/j.vaccine.2025.128182_bb0090","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(22)00094-0","article-title":"Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study","volume":"399","author":"Costa Clemens","year":"2022","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2025.128182_bb0095","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous Covid-19 booster vaccinations","volume":"386","author":"Atmar","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-024-00919-8","article-title":"Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced omicron subvariant binding","volume":"9","author":"Hartley","year":"2024","journal-title":"Npj Vaccines"},{"issue":"47","key":"10.1016\/j.vaccine.2025.128182_bb0105","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1016\/j.vaccine.2023.10.011","article-title":"Effectiveness of homologous\/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries","volume":"41","author":"Riefolo","year":"2023","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128182_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26335","article-title":"Durability of heterologous and homologous COVID-19 vaccine boosts","volume":"5","author":"Tan","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128182_bb0115","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1016\/S2214-109X(22)00112-7","article-title":"Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study","volume":"10","author":"Jara","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128182_bb0120","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.128182_bb0125","article-title":"Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case\u2013control study","author":"Gonz\u00e1lez","year":"2023","journal-title":"Lancet Reg Health \u2013 Am [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0130","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41598-024-84392-2","article-title":"Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand","volume":"15","author":"Ward","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128182_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1237916","article-title":"Homologous versus heterologous prime-boost COVID-19 vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial","author":"Sharifi Aliabadi","year":"2023","journal-title":"Front Immunol [Internet]"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128182_bb0140","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa2116747","article-title":"Immunogenicity and Reactogenicity of vaccine boosters after Ad26.COV2.S priming","volume":"386","author":"Sablerolles","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128182_bb0145","series-title":"Messenger RNA encoding the full-length SARS-CoV-2 spike glycoprotein","year":"2020"},{"key":"10.1016\/j.vaccine.2025.128182_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.789427","article-title":"The critical contribution of Pseudouridine to mRNA COVID-19 vaccines","volume":"9","author":"Morais","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2025.128182_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jbiotec.2020.12.005","article-title":"Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells","volume":"326","author":"Stuible","year":"2021","journal-title":"J Biotechnol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128182_bb0160","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1080\/21645515.2017.1423154","article-title":"Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants","volume":"14","author":"Akache","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"6179","key":"10.1016\/j.vaccine.2025.128182_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.128182_bb0170","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1038\/s41598-022-13819-5","article-title":"Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters","volume":"12","author":"Stark","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128182_bb0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/pharmaceutics13020205","article-title":"The synergistic effects of sulfated Lactosyl Archaeol Archaeosomes when combined with different adjuvants in a murine model","volume":"13","author":"Jia","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128182_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00758-23","article-title":"Immune imprinting of SARS-CoV-2 responses: changing first immune impressions","volume":"9","author":"Torresi","year":"2024","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128182_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/cimm.1994.1078","article-title":"IFN-\u03b3 stimulates IgG2 production from bovine B cells Costimulated with anti-\u03bc and mitogen","volume":"154","author":"Estes","year":"1994","journal-title":"Cell Immunol"},{"issue":"40","key":"10.1016\/j.vaccine.2025.128182_bb0190","doi-asserted-by":"crossref","first-page":"17292","DOI":"10.1073\/pnas.1004879107","article-title":"IFN-\u03b3 produced by CD8 T cells induces T-bet\u2013dependent and \u2013independent class switching in B cells in responses to alum-precipitated protein vaccine","volume":"107","author":"Mohr","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128182_bb0195","first-page":"4948","article-title":"Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2","volume":"153","author":"Kawano","year":"1994","journal-title":"J Immunol Baltim Md 1950"},{"issue":"66","key":"10.1016\/j.vaccine.2025.128182_bb0200","doi-asserted-by":"crossref","first-page":"eabl5344","DOI":"10.1126\/sciimmunol.abl5344","article-title":"BNT162b2 vaccination induces durable SARS-CoV-2\u2013specific T cells with a stem cell memory phenotype","volume":"6","author":"Guerrera","year":"2021","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00684-0","article-title":"Analyzing immune responses to varied mRNA and protein vaccine sequences","volume":"8","author":"Park","year":"2023","journal-title":"Npj Vaccines"},{"issue":"19","key":"10.1016\/j.vaccine.2025.128182_bb0210","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1056\/NEJMc2302462","article-title":"Durability of bivalent boosters against omicron subvariants","volume":"388","author":"Lin","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128182_bb0215","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/infdis\/jiad353","article-title":"SARS-CoV-2 hybrid immunity: the best of both worlds","volume":"228","author":"Lasrado","year":"2023","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128182_bb0220","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1016\/j.ymthe.2025.08.008","article-title":"mRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverage","volume":"33","author":"Ciancaglini","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128182_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1406138","article-title":"Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency","author":"Song","year":"2024","journal-title":"Front Immunol [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.smim.2007.12.002","article-title":"Plasma cell development: from B-cell subsets to long-term survival niches","volume":"20","author":"Fairfax","year":"2008","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2025.128182_bb0235","article-title":"An Inflammatory Loop Between Spleen-Derived Myeloid Cells and CD4+ T Cells Leads to Accumulation of Long-Lived Plasma Cells That Exacerbates Lupus Autoimmunity","author":"Jang","year":"2021","journal-title":"Front Immunol [Internet]"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41591-024-03278-y","article-title":"SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination","volume":"31","author":"Nguyen","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128182_bb0245","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/infdis\/jiad603","article-title":"Deficient generation of spike-specific long-lived plasma cells in the bone marrow after severe acute respiratory syndrome coronavirus 2 infection","volume":"230","author":"Tehrani","year":"2024","journal-title":"J Infect Dis"},{"issue":"728","key":"10.1016\/j.vaccine.2025.128182_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add5960","article-title":"Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates","volume":"16","author":"Prabhakaran","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.128182_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbiotec.2018.06.307","article-title":"Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells","volume":"281","author":"Stuible","year":"2018","journal-title":"J Biotechnol"},{"issue":"35","key":"10.1016\/j.vaccine.2025.128182_bb0260","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6483","key":"10.1016\/j.vaccine.2025.128182_bb0265","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"52","key":"10.1016\/j.vaccine.2025.128182_bb0270","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2025.128182_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2019.02.041","article-title":"A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations","volume":"561","author":"Jia","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2025.128182_bb0285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/978-1-0716-0795-4_31","article-title":"Measurement of antigen-specific IgG titers by direct ELISA","volume":"2183","author":"Akache","year":"2021","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.vaccine.2025.128182_bb0290","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-0716-0795-4_30","article-title":"The quantification of antigen-specific T cells by IFN-\u03b3 ELISpot","volume":"2183","author":"Akache","year":"2021","journal-title":"Methods Mol Biol Clifton NJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2501480X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2501480X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:47:48Z","timestamp":1773971268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2501480X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"alternative-id":["S0264410X2501480X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128182","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous vs. homologous vaccine regimens: Sulfated lactosyl archaeol (SLA) archaeosome-adjuvanted SARS-CoV-2 spike protein boost following an mRNA\/LNP prime induces robust and balanced immune responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128182"}}